Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in Oncorus, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ONCR is no longer listed, so this page shows Q1 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 32
- −1 vs. Q4 2022
- Shares held
- 11.0M
- −4.62M (−29.6%) vs. Q4 2022
- Total value
- $3.78M
- −$173.1K (−4.4%) vs. Q4 2022
- New holders
- 3
- 3 more added
- Sold out
- 4
- 13 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $3 |
| Q2 2023 | 4 | $212.1K |
| Q1 2023 | 32 | $3.78M |
| Q4 2022 | 33 | $3.95M |
| Q3 2022 | 40 | $14.1M |
| Q2 2022 | 45 | $21.4M |
| Q1 2022 | 56 | $34.5M |
| Q4 2021 | 56 | $107.1M |
| Q3 2021 | 48 | $186.2M |
| Q2 2021 | 50 | $282.6M |
| Q1 2021 | 57 | $278.2M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Oncorus, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Asset Management LLC | 2,849,464 | $980.2K | 0.41% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,377,031 | $817.7K | 0.21% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,367,436 | $814.6K | 0.22% | 00.0% | Unchanged |
| Fosun International Ltd | 962,323 | $327.2K | 0.03% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 540,258 | $185.9K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 475,345 | $163.6K | 0.00% | −20,568−4.1% | Reduced |
| Millennium Management LLC | 286,667 | $99.0K | 0.00% | +10,309+3.7% | Added |
| Renaissance Technologies LLC | 144,000 | $50.0K | 0.00% | −142,936−49.8% | Reduced |
| BlackRock Inc. | 139,040 | $47.8K | 0.00% | −632−0.5% | Reduced |
| Geode Capital Management, LLC | 135,751 | $46.7K | 0.00% | −2,176−1.6% | Reduced |
| SG Americas Securities, LLC | 126,525 | $44.0K | 0.00% | +53,833+74.1% | Added |
| We Are One Seven, LLC | 116,354 | $40.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 75,712 | $26.1K | 0.00% | −23,488−23.7% | Reduced |
| State Street Corp | 70,135 | $24.1K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 67,300 | $23.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 66,498 | $22.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 51,680 | $17.8K | 0.00% | −11,112−17.7% | Reduced |
| Northern Trust Corp | 28,525 | $9.82K | 0.00% | −435−1.5% | Reduced |
| Citadel Advisors LLC | 25,999 | $8.95K | 0.00% | −1,898,423−98.6% | Reduced |
| HSBC Holdings PLC | 26,452 | $8.73K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,525 | $6.03K | 0.00% | +17,525 | New |
| UBS Group AG | 14,650 | $5.04K | 0.00% | +14,650 | New |
| Goldman Sachs Group Inc | 10,195 | $3.51K | 0.00% | −6,994−40.7% | Reduced |
| Barclays PLC | 9,495 | $3.27K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,581 | $3.00K | 0.00% | −21−0.2% | Reduced |
| Morgan Stanley | 4,506 | $1.55K | 0.00% | −3,888−46.3% | Reduced |
| Bank of America Corp | 823 | $283 | 0.00% | −43,965−98.2% | Reduced |
| Wells Fargo & Company | 135 | $46 | 0.00% | +2+1.5% | Added |
| Allworth Financial LP | 100 | $35 | 0.00% | +100 | New |
| Your Advocates Ltd., LLP | 100 | $34 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 353 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 225 | $0 | 0.00% | −3−1.3% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −2,536,186−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −14,707−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,972−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −506−100.0% | Sold out |